<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05041465</url>
  </required_header>
  <id_info>
    <org_study_id>1296789</org_study_id>
    <nct_id>NCT05041465</nct_id>
  </id_info>
  <brief_title>The Cosmetic Effect of Mineral Clay Masks</brief_title>
  <official_title>The Cosmetic Effect of Mineral Clay Masks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the cosmetic effects of commercially available mineral&#xD;
      clay masks over a 4-week period. Changes in skin pigmentation, shine, wrinkles, and texture&#xD;
      will be assessed.&#xD;
&#xD;
      A second aim of the study is to assess the safety and tolerability of mineral clay masks by&#xD;
      assessing redness and participant feedback.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Count of Participants with Decrease in Skin pigmentation intensity at 4 Weeks</measure>
    <time_frame>4 weeks</time_frame>
    <description>Computer and photography based facial image analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>% of Participants with Skin redness intensity improvement at 4 weeks</measure>
    <time_frame>4 weeks</time_frame>
    <description>Computer and photography based facial image analysis</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient tolerability survey</measure>
    <time_frame>4 weeks</time_frame>
    <description>Survey to grade for side effects</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Rhytides</condition>
  <arm_group>
    <arm_group_label>French Green Clay Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Rhassoul Clay Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bentonite Clay Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clay mask</intervention_name>
    <description>Clay mask powders- French green, Rhassul and bentonite</description>
    <arm_group_label>Bentonite Clay Mask</arm_group_label>
    <arm_group_label>French Green Clay Mask</arm_group_label>
    <arm_group_label>Rhassoul Clay Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals aged 18-50&#xD;
&#xD;
          -  Individuals in good general health&#xD;
&#xD;
          -  Individuals free of any autoimmune or systemic disorder, which would interfere with&#xD;
             the analysis.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals who have been on any topical prescribed medications for the past 2 weeks&#xD;
&#xD;
          -  Individuals who have history of acute or chronic disease that would likely interfere&#xD;
             with or increase the risk on study participation at the discretion of the investigator&#xD;
&#xD;
          -  Individuals with active (flaring) disease or chronic skin allergies (atopic&#xD;
             dermatitis/eczema) or those who have recently undergone treatment for skin cancer&#xD;
             (within the last 12 months) in the area of testing on the forehead, nose and the&#xD;
             cheeks&#xD;
&#xD;
          -  Female volunteers who are pregnant or planning to become pregnant over the course of&#xD;
             the study. The risk to pregnant women is minimal but the facial appearance can be&#xD;
             confounded by the altered hormones associated with pregnancy, as is well documented in&#xD;
             chloasma which is dyspigmentation that arises in pregnancy. Women who become pregnant&#xD;
             during the duration of the study will become ineligible but there are no birth control&#xD;
             requirements.&#xD;
&#xD;
          -  Female volunteers who have started a new hormonal birth control agent or switched to a&#xD;
             hormonal birth control agent within the past 60 days&#xD;
&#xD;
          -  Individuals who have had any medical or cosmetic procedure, such as laser resurfacing,&#xD;
             or plastic surgery to the test site (face) within the last 6 months. This includes&#xD;
             botulinum toxin, dermal fillers, collagen or other similar cosmetic procedure&#xD;
&#xD;
          -  Individuals who are currently using or during the past 14 days have used a retinoid&#xD;
             such as tretinoin, adapalene, or retinol containing agents or a hydroquinone&#xD;
             containing agent&#xD;
&#xD;
          -  Individuals who have used mineral clay masks on their face within the last 14 days&#xD;
&#xD;
          -  Individuals with a known history of hypersensitivity to any ingredients to the agent&#xD;
             that is being assessed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of California Davis</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>September 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2021</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

